These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Monoclonal antibody to anti-VCAM-1 interferes with murine cardiac allograft rejection. Pelletier R; Ohye R; Kincade P; Ferguson R; Orosz C Transplant Proc; 1993 Feb; 25(1 Pt 1):839-41. PubMed ID: 7679845 [No Abstract] [Full Text] [Related]
12. Stability of tolerance in mice generated by CD4 and CD8 monoclonal antibody treatment: cell transfer experiments. Chen Z; Cobbold S; Waldmann H; Metcalfe S Transplant Proc; 1993 Feb; 25(1 Pt 1):790-1. PubMed ID: 8438482 [No Abstract] [Full Text] [Related]
13. The induction of transplantation tolerance using donor antigen and CD4 monoclonal antibody. Pearson TC; Madsen JC; Morris PJ; Wood KJ Transplant Proc; 1990 Aug; 22(4):1955-6. PubMed ID: 2389494 [No Abstract] [Full Text] [Related]
14. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model. Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564 [TBL] [Abstract][Full Text] [Related]
15. Prolongation in murine cardiac allograft survival with monoclonal antibodies to LFA-1, ICAM-1, and CD4. Jendrisak M; Jendrisak G; Gamero J; Mohanakumar T Transplant Proc; 1993 Feb; 25(1 Pt 1):825-7. PubMed ID: 8094914 [No Abstract] [Full Text] [Related]
16. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration. Otomo N; Margenthaler JA; Motoyama K; Arima T; Shimizu Y; Lehmann M; Flye MW J Surg Res; 2001 Jun; 98(1):59-65. PubMed ID: 11368539 [TBL] [Abstract][Full Text] [Related]
17. Devising murine models to better adapt clinical protocols: sequential low-dose treatment with anti-CD3 and anti-CD4 monoclonal antibodies to prevent fully mismatched allograft rejection. Campos HH; Bach JF; Chatenoud L Transplant Proc; 1993 Feb; 25(1 Pt 1):798-9. PubMed ID: 8438486 [No Abstract] [Full Text] [Related]
18. Anti-CD4 monoclonal antibody-induced allograft survival is associated with a defect in interleukin-2-dependent T-cell activation. Pearson TC; Hamano K; Morris PJ; Wood KJ Transplant Proc; 1993 Feb; 25(1 Pt 1):786-7. PubMed ID: 8438480 [No Abstract] [Full Text] [Related]
19. Beneficial effects of monoclonal antibody targeting of CD4+ cells during the sensitisation but not effector phase of accelerated rejection of rat cardiac allografts. Hancock WW; Sablinski T; Milford EL; Tilney NL; Atkins RC; Kupiec-Weglinski JW Transplant Proc; 1990 Oct; 22(5):2115-6. PubMed ID: 2219313 [No Abstract] [Full Text] [Related]